Ornithine decarboxylase (ODC) is the first and rate-controlling enzyme in the synthesis of polyamines, which are essential for normal cell growth. We have previously demonstrated that IL-4 and IL-13 can stimulate rat aortic smooth muscle cell ( 
INTRODUCTION
Vascular smooth muscle cell (VSMC) proliferation is a key event in the development of atherosclerosis and angioplasty-induced restenosis (55) . However, the mechanisms responsible for smooth muscle cell proliferation are not fully elucidated. The polyamines putrescine, spermidine and spermine have been shown to be essential for cell growth and differentiation. Putrescine is generated from the cationic amino acid L-ornithine via a decarboxylation reaction catalyzed by the enzyme ornithine decarboxylase (ODC), whereas spermidine and spermine are formed by the sequential transfer of an aminopropyl group from S-adenosylmethionine (33) . Smooth muscle cell proliferation induced by arterial injury, platelet-derived growth factor (PDGF), thrombin, insulin, basic fibroblast growth factor (bFGF), transforming growth factor -1 (TGF-beta1) and serum are all associated with a striking increase in ODC activity (10, 14, 18, 26) . The ODC gene is now recognized as a proto-oncogene required for cell-cycle progression and transformation. ODC is one of the most highly regulated enzymes known (25) . ODC activity is tightly regulated at four levels, namely gene transcription, mRNA degradation, mRNA translation, and protein degradation (44) . An elevated cellular concentration of polyamines induces upregulated expression of antizyme, an ODC-inhibitory protein that binds ODC and induces its rapid degradation (29) . This degradation leads to a fast turnover of ODC, which has a half-life of only 10-20 min. The cellular concentration of ODC is very low, estimated to comprise 0.0003-0.01% of total cellular proteins (19) .
IL-4 is a multifunctional cytokine that plays a critical role in the regulation of immune responses. IL-13 is a cytokine that elicits biological responses similar to IL-4.
IL-4 mRNA has been found in human and mouse atherosclerotic lesions (58) . induces transcription of the 15-lipoxygenase-I gene in human endothelial cells, which plays an important role in atherogenesis (24) . More recently, IL-4 has been linked to cigarette smoke induced atherosclerotic lesion formation (31). At present, relatively little is known about how increasing the production of IL-4 affects atherosclerotic plaque formation. In our previous study, we found that both IL-4 and IL-13 can upregulate arginase I expression and stimulate cell proliferation in rat aortic smooth muscle cells (RASMC) (53) . Arginase catalyzes the conversion of arginine to ornithine plus urea.
Ornithine is, in turn, converted to putrescine by ODC. We have also found that elevated Page 3 of 27 expression of arginase I in RASMC increases polyamine production (54) . Since ODC is the first and rate-limiting enzyme in polyamine synthesis, we reasoned that IL-4 and IL-13 may upregulate ODC expression and subsequently generate more polyamines available to stimulate cell growth. The objective of the present study was to determine whether ODC expression can be regulated by IL-4 and IL-13, and if ODC activity correlates with RASMC proliferation. In the present study, IL-4 and IL-13 were shown to significantly increase ODC activity. The signal transduction pathways regulating ODC induction were investigated. MEK/ERK (extracellular-signal-regulated kinase), PI3K and PKA pathways were all shown to modulate ODC expression and activity.
Dexamethasone completely abolished the response of RASMC to IL-4 and IL-13. To the best of our knowledge this is the first study to investigate the effects of IL-4 and IL-13 on the regulation of ODC expression in any cell line. Our data suggest that IL-4 and IL-13 may play an important role in vascular smooth muscle cell growth and atherosclerotic plaque formation.
MATERIALS AND METHODS
Reagents. Dexamethasone was purchased from Sigma. H-89, LY 294002 and PD 98059 were purchased from Calbiochem. Rat recombinant IL-4 and IL-13 were purchased from Peprotech.
Cell culture of RASMC. RASMC was a generous gift from Dr. Steven Gross. Cells were plated in high-glucose DMEM-HEPES supplemented with 10% FBS, 2 mM glutamine, 1 mM sodium pyruvate, 100 u/ml penicillin, 100 µg/ml streptomycin, and 0.25 mg/ml amphotericin B and were grown until confluent, then subcultured by trypsinization. Cell cultures were performed at 37°C in a humidified atmosphere of 5% CO 2 -95% air. Subculture strains were used between passages 20-28. Cells were plated at a density of 10 6 cells/100-mm dishes. When cells reached 80% confluence, the culture medium was replaced with fresh DMEM-HEPES and experiments were started.
Ornithine decarboxylase assay. ODC activity was determined by monitoring the formation of [ Northern blot analysis of ODC mRNA level. RNA was isolated using commercially available kits (QIAshredder and RNeasy Total RNA; Qiagen). Northern blot analysis was performed by standard techniques for formaldehyde-containing agarose gels (21) . Mouse cDNA probe (ATCC) for ODC was labeled by random priming (Ambion) to a specific activity of > 10 9 dpm/mg with [ - 32 P]dCTP and added (10 6 dpm/ml) to the prehybridization solution (5 x SSPE containing 50% formamide, 5 x Denhardt's solution, 0.1% SDS, 100 µg/ml heat-chilled salmon sperm DNA). Membranes were washed to a final stringency of 15 mM NaCl at 37°C and exposed overnight to Hyperfilm MP X-ray film (Amersham) using intensifying screens at -70°C. To normalize hybridization signals for variations in loading and /or transfer, membranes were probed with GAPDH (Ambion). Densitometry of the bands was performed on the autoradiography film using a Helwlettt-Packard flatbed scanner and NIH Image densitometry software. h. The cells were collected for determining rates of DNA synthesis according to procedures described previously (53) .
Statistical analyses. Data are presented as mean ± SE. Differences between the groups were analyzed by ANOVA. Probability values of < 0.05 were taken to indicate statistical significance. Fig 1A. illustrates that RASMC contain basal ODC activity, and incubation of cells with IL-4 (10 ng/ml) or IL-13 (10 ng/ml) significantly increased ODC activity (4-to 5-fold). Interleukin concentrations of 10 ng/ml were selected on the basis of pilot experiments on ODC activity and expression, which indicated that such concentrations elicited maximal or near maximal effects. IL-4 and IL-13 concentrations of 1 to 3 ng/ml showed less activity and concentrations less than 1 ng/ml were inactive.
RESULTS

ERK and PI3K signal transduction pathways regulate ODC gene expression and activity in RASMC.
Next we wanted to evaluate if ERK and PI3K signaling pathways were involved in the The ODC mRNA level reached a maximum at 6 h after serum stimulation, decreased dramatically at 18 h, and returned to basal levels at 24 h. Therefore, 10% FBS stimulated ODC mRNA expression was transient. In the presence of IL-4 or IL-13, however, ODC mRNA reached a maximum at 6 h and remained constant until 24 h (Fig. 5A and Fig.   6A ). Relative densitometry data ( Fig. 5B and Fig. 6B ) illustrated that significant increase of ODC mRNA expression was observed at 18 and 24 h compared with control group 
DISCUSSION
This study demonstrates that IL-4 and IL-13 both significantly upregulate ODC activity in RASMC, and that this is attributed to an increase in ODC mRNA expression.
The increase in ODC activity was associated with an increase in polyamine production and cell proliferation. We further demonstrated that the PI3K inhibitor PD98059, the MAPK inhibitor LY294002, and the PKA inhibitor H-89 nearly completely blocked the upregulation of ODC expression induced by IL-4 and IL-13, and these effects were paralleled by a decrease in both polyamine production and cell proliferation.
Dexamethasone, which is a known inhibitor of cell proliferation (38, 39) reduced both basal ODC expression and induced ODC expression by IL-4 and IL-13. This is the first report indicating that ODC expression and activity can be increased by IL-4 and IL-13 and that this effect accounts for the capacity of these two cytokines to promote cell proliferation. The present study was conducted to elucidate the mechanism(s) by which IL-4
IL-4 regulates
and IL-13 stimulate vascular smooth muscle cell proliferation. In a previous study, we found that both cytokines could increase arginase I expression (53) which is consistent with increased polyamine production and cell growth (54) . However, the present study reveals that IL-4 and IL-13 also upregulate ODC expression and activity and cause an increase in polyamine production that is associated with increased RASMC proliferation.
By employing classical inhibitor experiments, we found that the PI3K, MAPK and PKA signaling pathways are involved in the effects of IL-4 and IL-13. We were interested in this approach as a possible explanation for the increased proliferation of vascular smooth muscle and other cell types that characterizes atherosclerosis (42) . The present study as well as a previous study (54) suggest that vascular smooth muscle proliferation in atherosclerosis, a complex inflammatory disease characterized by increased cytokine production, may be at least partially attributed to arginase I induction, ODC induction, and consequent increased polyamine production. A possible scenario is that during atherogenesis, cytokines such as IL-4 and IL-13 produced by local lymphocytes (41, 43) NK cells (32) and vascular endothelial cells (3, 37) upregulate both arginase I and ODC expression in nearby vascular smooth muscle cells and stimulate their growth.
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